These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Botulinum toxin type A and cholinergic system]. Bach-Rojecky L; Relja M; Filipović B; Lacković Z Lijec Vjesn; 2007 Dec; 129(12):407-14. PubMed ID: 18383744 [TBL] [Abstract][Full Text] [Related]
5. Do the unintended actions of botulinum toxin at distant sites have clinical implications? Currà A; Berardelli A Neurology; 2009 Mar; 72(12):1095-9. PubMed ID: 19307544 [TBL] [Abstract][Full Text] [Related]
6. A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A. Hexsel D; Dal'Forno T; Hexsel C; Do Prado DZ; Lima MM Dermatol Surg; 2008 Jan; 34(1):52-9. PubMed ID: 18053050 [TBL] [Abstract][Full Text] [Related]
7. Effects of botulinum toxin A on functional outcome during distraction osteogenesis. Olabisi R; Best TM; Vanderby R; Petr S; Noonan KJ J Orthop Res; 2007 May; 25(5):656-64. PubMed ID: 17262822 [TBL] [Abstract][Full Text] [Related]
8. Effect of fresh and stored botulinum toxin a on muscle and nerve ultrastructure: an electron microscopic study. Elmas C; Ayhan S; Tuncer S; Erdogan D; Calguner E; Basterzï Y; Gozil R; Bahcelioglu M Ann Plast Surg; 2007 Sep; 59(3):316-22. PubMed ID: 17721223 [TBL] [Abstract][Full Text] [Related]
10. Afferent input modulates neurotrophins and synaptic plasticity in the spinal cord. Gómez-Pinilla F; Ying Z; Roy RR; Hodgson J; Edgerton VR J Neurophysiol; 2004 Dec; 92(6):3423-32. PubMed ID: 15548637 [TBL] [Abstract][Full Text] [Related]
11. Restoring balance in focal limb dystonia with botulinum toxin. Sheean G Disabil Rehabil; 2007 Dec; 29(23):1778-88. PubMed ID: 18033603 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin: mechanisms of action. Dressler D; Adib Saberi F Eur Neurol; 2005; 53(1):3-9. PubMed ID: 15650306 [TBL] [Abstract][Full Text] [Related]
13. Botox produces functional weakness in non-injected muscles adjacent to the target muscle. Yaraskavitch M; Leonard T; Herzog W J Biomech; 2008; 41(4):897-902. PubMed ID: 18184613 [TBL] [Abstract][Full Text] [Related]
14. The effects of botulinum toxin A on muscle histology during distraction osteogenesis. Olabisi R; Chamberlain CS; Petr S; Steiner S; Consigny D; Best TM; Vanderby R; Schultz E; Noonan KJ J Orthop Res; 2009 Mar; 27(3):310-7. PubMed ID: 18752291 [TBL] [Abstract][Full Text] [Related]
15. [The effectiveness of Botulinum toxin Type A in two cases of abdominal myoclonias refractory to conventional therapy]. Vivancos-Matellano F; Arpa-Gutiérrez FJ; Pérez-Conde MC; del Río-Villegas R; Martínez-Castrillo JC Rev Neurol; 2006 Jan 1-15; 42(1):59-61. PubMed ID: 16402329 [No Abstract] [Full Text] [Related]
16. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children. Ibrahim AI; Hawamdeh ZM; Al-Qudah AA Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584 [TBL] [Abstract][Full Text] [Related]
17. The effects of botulinum neurotoxin A induced muscle paresis during a critical period upon muscle and spinal cord development in the rat. Clowry GJ; Walker L; Davies P Exp Neurol; 2006 Dec; 202(2):456-69. PubMed ID: 16928374 [TBL] [Abstract][Full Text] [Related]
18. Effects of changes in pH on the afferent impulse activity of isolated cat muscle spindles. Fischer M; Schäfer SS Brain Res; 2005 May; 1043(1-2):163-78. PubMed ID: 15862530 [TBL] [Abstract][Full Text] [Related]
19. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. Wissel J; Entner T Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048 [TBL] [Abstract][Full Text] [Related]
20. Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation. Minamoto VB; Hulst JB; Lim M; Peace WJ; Bremner SN; Ward SR; Lieber RL Dev Med Child Neurol; 2007 Dec; 49(12):907-14. PubMed ID: 18039237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]